Evidence map›Paper›PMID 32901959›Full record

ArticleBritish journal of clinical pharmacology2021

Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands.

W E Ellen van Loon, S D Sander Borgsteede, G W Gert Baas, M Martine Kruijtbosch, H Henk Buurma, P A G M Peter De Smet, A C G Toine Egberts, M Marcel Bouvy, A Annemieke Floor-Schreudering

Abstract read
In one paragraph

Article in British journal of clinical pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

W E Ellen van LoonSIR Institute for Pharmacy Practice and Policy, Leiden, the Netherlands.ORCID 0000-0003-3173-1933
S D Sander BorgsteedeSIR Institute for Pharmacy Practice and Policy, Leiden, the Netherlands.ORCID 0000-0002-8425-6139
G W Gert BaasDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
M Martine KruijtboschSIR Institute for Pharmacy Practice and Policy, Leiden, the Netherlands.ORCID 0000-0002-4725-5292
H Henk Buurma
P A G M Peter De SmetDepartment of Clinical Pharmacy, University Medical Centre St Radboud, Nijmegen, the Netherlands.ORCID 0000-0003-1762-6547
A C G Toine EgbertsDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0003-1758-7779
M Marcel BouvySIR Institute for Pharmacy Practice and Policy, Leiden, the Netherlands.ORCID 0000-0002-4596-0684
A Annemieke Floor-SchreuderingSIR Institute for Pharmacy Practice and Policy, Leiden, the Netherlands.

Funding

Royal Dutch Pharmacists Association (Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, KNMP)
6 · The paper itself

Abstract

aimsTo investigate the nature and frequency of prescription modifications in Dutch community pharmacies.

methodsIn this cross-sectional study, Dutch community pharmacists documented prescription modifications in their pharmacy during 1 predetermined day. Pharmacists from all Dutch community pharmacies were invited to participate. A prescription modification was defined as any modification in a prescription for a medicine or other healthcare product because of an administrative problem, logistic issue or potential drug-related problem (DRP). All documented modifications were assessed to establish the nature and frequency of prescription modifications.

resultsPharmacists in 275 pharmacies completed the study. A modification was performed in 5.5% of all prescriptions. 1.3% of the prescriptions contained an administrative problem, of which insufficient specification of the dosing regimen was most common (63.1%). A modification was performed due to a logistic issue in 2.4% of the prescriptions. The most frequently recorded issues were unavailability of medication (40.9%) and obligatory product substitutions due to reimbursement policies (33.2%). A modification was performed in 1.8% of the prescriptions to solve or prevent potential DRPs. Of these, 69.2% was potentially clinically relevant according to the pharmacist concerned. The most frequently prevented potential DRP was an incorrect strength or dose (31.9%).

conclusionDutch community pharmacists modified almost 1 in 20 prescriptions per pharmacy. The nature of the modifications reflects current community pharmacy practice, in which pharmacists frequently deal with logistic issues and intervene to solve or prevent for DRPs several times a day. The majority of the DRPs were considered to be potentially clinically relevant.

Indexed as

Community Pharmacy ServicesPharmaciesCross-Sectional StudiesDrug PrescriptionsHumansNetherlandsPharmacistscommunity pharmacydrug-related problemsinterventionsmedication errorsmedication safetypharmacistsprescribing errorsprescription modificationsprimary health care

Identifiers

PMID32901959
PMCPMC9328355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.